Brief: Eterna Therapeutics Announces Initiation Of Development Activities For Hypoimmune Pluripotent Cell Line For Neurology Indications Under Partnership With Lineage Cell Therapeutics
06/09/2023 16:17
Eterna Therapeutics Inc ERNA.O :
* ETERNA THERAPEUTICS ANNOUNCES INITIATION OF DEVELOPMENT
ACTIVITIES FOR HYPOIMMUNE PLURIPOTENT CELL LINE FOR NEUROLOGY
INDICATIONS UNDER PARTNERSHIP WITH LINEAGE CELL THERAPEUTICS
Source text for Eikon: ID:nGNX5F8ylj
Further company coverage: ERNA.O